
|Articles|November 12, 2012
Not Enough Cancer Drugs, Too Many Price Controls
Advertisement
Cancer patients face daunting challenges, including side effects of treatment, impact on family life and work disruptions. They now face another problem: shortages of vital drugs.
Imagine an oncologist talking to his patient: Everything is going well with your treatment, he says, but one of the drugs you've been receiving is unavailable. There's a substitute—sort of. Your Medicare copayment for the drug we've been using is $9. Now it will cost you $520 each time the substitute is given.
Read the full story:
Source: The Wall Street Journal
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show
2
Primary Care Capacity Gaps Threaten Respiratory Prevention
3
COPERNICOS Trial: Eosinophil-Guided ICS Reduction Safe in COPD, Vestbo Says
4
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
5




